NCT04876781
- Conditions
- Active Ankylosing Spondylitis, Active Moderate to Severe Rheumatoid Arthritis, Active Psoriatic Arthritis
- Locations
-
- Pfizer Seoul, South Korea
Clinical trial condition
Active Moderate to Severe Rheumatoid Arthritis
Explore clinical trials studying Active Moderate to Severe Rheumatoid Arthritis. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study